| Bioactivity | Picotamide is a combined inhibitor of thromboxane A2 (TxA2) synthase and receptor. Picotamide has antiplatelet activity. Picotamide promotes the reduction of microalbuminuria and the inhibition of growth of carotid plaques in diabetes. Picotamide can be used for researching acute or chronic cardiovascular diseases[1]. | |||||||||
| Name | Picotamide | |||||||||
| CAS | 32828-81-2 | |||||||||
| Formula | C21H20N4O3 | |||||||||
| Molar Mass | 376.41 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Celestini A, et al. A review of picotamide in the reduction of cardiovascular events in diabetic patients. Vasc Health Risk Manag. 2007;3(1):93-98. |
Picotamide
CAS: 32828-81-2 F: C21H20N4O3 W: 376.41
Picotamide is a combined inhibitor of thromboxane A2 (TxA2) synthase and receptor. Picotamide has antiplatelet activity.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.